AOTCX
Price
$28.99
Change
-$0.11 (-0.38%)
Updated
Dec 20 closing price
RNWFX
Price
$77.72
Change
+$0.12 (+0.15%)
Updated
Dec 20 closing price
Ad is loading...

AOTCX vs RNWFX

Header iconAOTCX vs RNWFX Comparison
Open Charts AOTCX vs RNWFXBanner chart's image
Virtus Emerging Markets Opps C
Price$28.99
Change-$0.11 (-0.38%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$77.72
Change+$0.12 (+0.15%)
VolumeN/A
CapitalizationN/A
AOTCX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AOTCX vs. RNWFX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AOTCX is a Buy and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 62.2B vs. AOTCX (161M). AOTCX pays higher dividends than RNWFX: AOTCX (1.92) vs RNWFX (1.51). AOTCX was incepted earlier than RNWFX: AOTCX (18 years) vs RNWFX (23 years). AOTCX is a more actively managed with annual turnover of: 109.00 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than AOTCX: RNWFX (250) vs AOTCX (2500). AOTCX annual gain was more profitable for investors over the last year : 7.56 vs. RNWFX (5.86). RNWFX return over 5 years is better than : 14.39 vs. AOTCX (11.73).
AOTCXRNWFXAOTCX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years23 years-
Gain YTD4.7124.549104%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets161M62.2B0%
Annual Yield % from dividends1.921.51127%
Returns for 1 year7.565.86129%
Returns for 3 years-4.49-5.1088%
Returns for 5 years11.7314.3981%
Returns for 10 years29.0342.6768%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTRS12.520.39
+3.22%
Viatris
TEO11.890.14
+1.19%
Telecom Argentina SA
DX12.570.14
+1.13%
Dynex Capital
INTT7.680.04
+0.52%
inTEST Corp
VIRX0.21N/A
-1.87%
Viracta Therapeutics